O CEO da Mirion Technologies, Thomas Logan, e a integrante da Mirum Pharmaceuticals, Pamela Vig, venderam ações por US$ 81.675 e US$ 1,039 milhão, respectivamente. Mirion Technologies CEO Thomas Logan and Mirum Pharmaceuticals insider Pamela Vig sold shares for $81,675 and $1.039 million, respectively.

O CEO da Mirion Technologies, Thomas Logan, vendeu 7.500 ações por US$ 81.675, deixando-o com 1,54 milhão de ações; Pamela Vig, membro da Mirum Pharmaceuticals, vendeu 30.559 ações por US$ 1,039 milhão, deixando-a com 27.406 ações. Mirion Technologies CEO Thomas Logan has sold 7,500 shares of stock for $81,675, leaving him with 1.54 million shares; Mirum Pharmaceuticals insider Pamela Vig sold 30,559 shares for $1.039 million, leaving her with 27,406 shares. O preço das ações da Mirion Technologies varia de US$ 6,70 a US$ 11,49, enquanto as ações da Mirum Pharmaceuticals variam de US$ 23,14 a US$ 35,56. Mirion Technologies' stock price ranges from $6.70 to $11.49, while Mirum Pharmaceuticals' stock has a range of $23.14 to $35.56.

Artigos

Modern Readers

Markets Daily

WKRB 13

Daily Political

Modern Readers

-- mostrar menos --

Histórias relacionadas